Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neptune Wellness Solutions Inc NEPTF

Neptune Wellness Solutions Inc. is a consumer-packaged goods company that is primarily focused on health and wellness products. The Company focuses on developing a portfolio of consumer products that align with the market trends for natural, sustainable, plant-based, and purpose-driven lifestyle brands. Its products are available in more than 29,000 retail locations and include organic food and beverage brands, such as Sprout Organics, Nosh, and Nurturme, as well as nutraceuticals brands like Biodroga and Forest Remedies. Its main brand units are nutraceuticals and organic foods and beverages. The Company sells its nutraceutical products mainly in bulk soft gels or liquids to multiple distributors and customers, who commercialize these products under their private label. The Company, through its Sprout subsidiary, sells its organic foods and beverages products to mass retailers, grocery stores and other retail outlets, as well as online through e-commerce sites and its own Website.


OTCPK:NEPTF - Post by User

Comment by gwrbion Aug 09, 2011 9:14am
360 Views
Post# 18920869

Results this week

Results this week
NTB's market cap is now $150M (based on a $3.50 SP).  Although nowhere near the crazy valuations of 2006/07 of $8++, the trading up near $4 over the last few months nows starts to apply a forward multiple based on some of the dream opportunities (and you've heard them all before - CaPre / Nestle / Yoplait / Bayer / capacity doubles, etc.).

Whether revenues in the past quarter are up or down $200K or $300K is irrelevant.  An upward trajectory would be nice, but at some point in time the revenues need to start showing a doubling effect.   The driver of the SP now (notwithstanding current volatility) is little connected to krill pill sales.  The CaPre advancement through clinical trials will be the big kicker.

I have been very impressed with NTB's resilience over the last week.  Was only down
.04 until late in the day yesterday.   It is becoming a much more credible investment everyday. 
Bullboard Posts